InvestorsHub Logo
Followers 19
Posts 4745
Boards Moderated 0
Alias Born 11/10/2016

Re: PINKribbon post# 82690

Thursday, 04/19/2018 7:39:09 PM

Thursday, April 19, 2018 7:39:09 PM

Post# of 144811
Merck announced new lung cancer trial results this week

They were more successful than Bristol Myer Squibb because they used immunotherapy with chemotherapy.

So if combination therapy is best with chemo. Then Ciab should be the best way to deliver chemo. It can focus the chemo and avoid side effects.

The best of both worlds.

Just saying that we are still very very relevant when the latest most successful results from Merck are a combination of immunotherapy and chemotherapy.

Now just imagine if you could have your chemo combination without side effects.

And just target the tumor and not the healthy parts of your body.

Ciab should be able to do that.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News